Product Information
VENLAFAXINE HCL ER 150 MG CAP is a generic product labeled by Major Pharmaceuticals, priced at $0.1169 per EA under NDC 00904748961. Its NADAC has been published 18 times since Feb 25, 2026.
Strength
150 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904748961
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200834On Market Since
10/8/2025
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 150 MG CAP has been published 18 times since Feb 25, 2026, and over the history we have for it it has declined 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1169 per EA |
|---|---|
| All-time high | $0.1239 (Mar 11, 2026) |
| All-time low | $0.1169 (Jun 17, 2026) |
| 52-week high | $0.1239 |
| 52-week low | $0.1169 |
| Median price | $0.1225 |
| Average price | $0.1217 |
| Largest weekly change | -2.4% (May 20, 2026) |
| Weeks tracked | 18 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 10 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 150 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 150 MG CAP, manufactured by Major Pharmaceuticals, is $0.1169 per EA (NDC 00904748961), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 150 MG CAP changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has declined 5.6%. It has been tracked across 18 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 150 MG CAP?
Since Feb 25, 2026, the NADAC for VENLAFAXINE HCL ER 150 MG CAP has ranged from a low of $0.1169 (Jun 17, 2026) to a high of $0.1239 (Mar 11, 2026), with a median of $0.1225 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 150 MG CAP?
10 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 150 MG CAP, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 150 MG CAP?
VENLAFAXINE HCL ER 150 MG CAP (NDC 00904748961) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification